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Abstract 
Introduction: Recent approaches on parasite diagnosis and immunoprophylaxis studies are 
based on the use of recombinant proteins. The aim of this work was to evaluate a novel fusion 
system in the production of a major component of the cyst wall structure of Giardia lamblia, 
CWP2, which has been studied for targeting new therapeutic agents against this important 
pathogen [Luján et al 1995]. It is also intended to obtain anti-CWP2 antibodies and to study its 
ability to recognize the surface of cysts. 
Methods: We designed primers to amplify and sub-cloned by PCR a part of the gene cwp2 that 
encodes the protein CWP2. This truncated protein was expressed in E. coli using a novel fusion 
system that significantly increases protein production yields. After its purification by affinity 
chromatography on Ni-NTA columns, CWP2 was dialysed against phosphate buffer pH 8.0 and 
later injected in mice. The immune response obtained in mice was then evaluated by ELISA and 
immunofluorescence assays. 
Results: When compared to the respective non-fused protein, CWP2 fused protein was 
expressed in E. coli with an increase of about 3 folds. Results from ELISA and 
immunofluorescence assays confirmed the potential diagnostic interest of CWP2 recombinant 
antigen. 
 Conclusions: Results from this work may provide an important advance on diagnostic and 
therapeutic field on giardiasis. 
 
